| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13D/A | Report | AVIDITY BIOSCIENCES, INC. | Aug 23, 2024 | |
| SC 13D/A | Report | SC 13D/A | Aug 7, 2024 | |
| SC 13D/A | Report | ALLURION TECHNOLOGIES INC. | Jul 2, 2024 | |
| SC 13D/A | Report | ALLURION TECHNOLOGIES INC. | Apr 17, 2024 | |
| SC 13D/A | Report | AVIDITY BIOSCIENCES, INC. | Mar 1, 2024 | |
| SC 13G/A | Report | BRAINSWAY LTD. | Feb 14, 2024 | |
| SC 13G | Report | GH RESEARCH PLC | Feb 14, 2024 | |
| SC 13G | Report | PHARMING GROUP N.V. | Feb 14, 2024 | |
| SC 13G/A | Report | RTW INVESTMENTS, LP | Feb 14, 2024 | |
| SC 13G/A | Report | IMMUNIC, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | FULCRUM THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | PMV PHARMACEUTICALS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | RELMADA THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | PROTAGONIST THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | ULTRAGENYX PHARMACEUTICAL INC. | Feb 14, 2024 | |
| SC 13G/A | Report | STOKE THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | VERICEL CORPORATION | Feb 14, 2024 | |
| SC 13G/A | Report | ESTABLISHMENT LABS HOLDINGS INC. | Feb 14, 2024 | |
| SC 13G/A | Report | CELLDEX THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | C4 THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | APYX MEDICAL CORPORATION | Feb 14, 2024 | |
| SC 13G/A | Report | ADICET BIO, INC | Feb 14, 2024 | |
| SC 13G/A | Report | TENAYA THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | TARSUS PHARMACEUTICALS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | AXSOME THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | PTC THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | EXAGEN INC. | Feb 14, 2024 | |
| SC 13G/A | Report | MIRATI THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G/A | Report | AVADEL PHARMACEUTICALS PLC | Feb 14, 2024 | |
| SC 13G/A | Report | MILESTONE PHARMACEUTICALS INC. | Feb 14, 2024 | |
| SC 13G | Report | 89BIO, INC. | Feb 14, 2024 | |
| SC 13G | Report | SAGE THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G | Report | TAYSHA GENE THERAPIES, INC. | Feb 14, 2024 | |
| SC 13G | Report | Feb 14, 2024 | ||
| SC 13G | Report | UROGEN PHARMA LTD. | Feb 14, 2024 | |
| SC 13G | Report | AKERO THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G | Report | ARVINAS, INC. | Feb 14, 2024 | |
| SC 13G | Report | ESSA PHARMA INC. | Feb 14, 2024 | |
| SC 13G | Report | SPYRE THERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13G | Report | SAB BIOTHERAPEUTICS, INC. | Feb 14, 2024 | |
| SC 13D/A | Report | AVIDITY BIOSCIENCES, INC. | Jan 24, 2024 | |
| SC 13G | Report | CUTERA, INC. | Jan 19, 2024 | |
| SC 13D/A | Report | DERMTECH, INC. | Dec 12, 2023 | |
| SC 13G | Report | CARGO THERAPEUTICS, INC. | Nov 24, 2023 | |
| SC 13D/A | Report | ROCKET PHARMACEUTICALS, INC. | Sep 19, 2023 | |
| SC 13D | Report | ALLURION TECHNOLOGIES INC. | Aug 11, 2023 | |
| SC 13D/A | Report | SC 13D/A | May 10, 2023 | |
| SC 13D/A | Report | May 5, 2023 | ||
| SC 13D | Report | CUTERA, INC. | Apr 13, 2023 | |
| SC 13D/A | Report | RENOVACOR, INC. | Apr 5, 2023 |